- Home
- AIRS vs PCF Comparison
AIRS vs PCF Comparison
Compare AIRS & PCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AIRS | PCF |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.6M | 113.0M |
| IPO Year | 2021 | 1994 |
Fundamental Metrics
Financial Performance| Metric | AIRS | PCF |
|---|---|---|
| Price | $2.03 | $5.81 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.50 | N/A |
| AVG Volume (30 Days) | ★ 537.6K | 92.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $180,350,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.55 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.51 | $5.73 |
| 52 Week High | $12.00 | $6.72 |
Technical Indicators
Market Signals| Indicator | AIRS | PCF |
|---|---|---|
| Relative Strength Index (RSI) | 50.36 | 30.99 |
| Support Level | $1.85 | N/A |
| Resistance Level | $3.29 | $6.46 |
| Average True Range (ATR) | 0.20 | 0.07 |
| MACD | 0.06 | -0.02 |
| Stochastic Oscillator | 84.92 | 1.39 |
Price Performance
Historical ComparisonAbout AIRS AirSculpt Technologies Inc.
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. Elite Body Sculpture, provides custom body contouring using the proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure. The company has one operating and reportable segment, direct medical procedure services.
About PCF High Income Securities Fund
High Income Securities Fund is a closed-end management investment company. Its primary objective is to provide high current income and capital appreciation is the secondary objective. The Fund pursues its objective mainly by investing in both convertible bonds and convertible preferred stocks. The Fund also invests significantly in high-yielding non-convertible securities with the potential for capital appreciation.